Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1633 1651
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17911391 | COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17795915 | COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 18036111 | MODULATING BHLHE40 IN THE DIFFERENTIATION OF TYPE 1 REGULATORY T CELLS AND CONTROLLING T CELL EXHAUSTION | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17762396 | CELL CULTURING MATERIALS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17609425 | AAV MUTANT THAT EFFICIENTLY INFECTS SUPPORTING CELLS | Final Rejection | CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES |
| 17292303 | ANCHORAGE-INDEPENDENT CELLS AND USE THEREOF | Non-Final OA | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
| 18304694 | METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18806560 | Viral vector packaging cells with tunable virus genes to optimize vector production and quality | Non-Final OA | CHO Plus, Inc. |
| 17624744 | METHOD FOR PRODUCING CULTURE MEDIUM COMPOSITION FOR SUSPENSION CULTURING ADHERENT CELLS | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 18076795 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE BASED ON HOST-MYCOBIOTA INTERACTIONS | Non-Final OA | Cornell University |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | Non-Final OA | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. |
| 18636969 | CELL CULTIVATION METHOD, CELL SUPPORT COMPOSITE PRODUCTION METHOD, CULTIVATED CELLS, AND CELL SUPPORT COMPOSITE | Non-Final OA | NIKKISO CO., LTD. |
| 18609070 | Use of Short Chain Fatty Acids in Cancer Prevention | Non-Final OA | Temple University-Of The Commonwealth System of Higher Education |
| 18310100 | COMPOSITIONS AND METHODS FOR PREPARATION OF RED BLOOD CELLS | Non-Final OA | Cerus Corporation |
| 17725324 | CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS | Final Rejection | Caribou Biosciences, Inc. |
| 17811685 | LONG POLY(A) PLASMIDS AND METHODS FOR INTRODUCTION OF LONG POLY(A) SEQUENCES INTO THE PLASMID | Non-Final OA | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
| 17310235 | OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Final Rejection | The Schepens Eye Research Institute, Inc. |
| 18039027 | MEDIUM COMPOSITION FOR DERMAL PAPILLA CELL GROWTH, CONTAINING ROTENONE AND ALBUMIN AS ACTIVE INGREDIENTS | Final Rejection | XCELL THERAPEUTICS INC. |
| 18129875 | RETINAL GRAFT AND METHOD OF PREPARATION | Final Rejection | Precise-Bio 3D LTD. |
| 18024324 | DETOXIFIED SECRETOME EXTRACT MADE FROM CULTURE SUPERNATANT OF MESENCHYMAL STEM CELLS OR PROGENITOR CELLS DERIVED FROM THE MESENCHYMAL STEM CELLS, AND METHOD FOR PRODUCING SAME | Non-Final OA | TELEBIO K.K. |
| 18115728 | SCAFFOLD, METHOD FOR PRODUCING SCAFFOLD, CELL CULTURE CONSTRUCT, METHOD FOR CULTURING CELL | Final Rejection | LEAVE A NEST CO, LTD. |
| 18021864 | BURN RESTORATION MATERIAL | Non-Final OA | SAKURA SEIKI CO., LTD. |
| 15898558 | COATED BIOLOGICAL COMPOSITION | Non-Final OA | Vivex Biologics Group, Inc. |
| 17640681 | METHOD FOR OBTAINING HEALTHY INTESTINAL ORGANOIDS | Non-Final OA | PRECISION CANCER TECHNOLOGIES INC. |
| 17453143 | FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE | Final Rejection | SpinalCyte, LLC |
| 16305910 | METHOD FOR PRODUCING A PLATELET-LYSATE-CONTAINING GEL | Non-Final OA | PL BIOSCIENCE GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy